- Home
- VINP vs PRME Comparison
VINP vs PRME Comparison
Compare VINP & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | PRME |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.0M | 666.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VINP | PRME |
|---|---|---|
| Price | $10.85 | $3.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $14.00 | $7.56 |
| AVG Volume (30 Days) | 79.2K | ★ 1.7M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.63% | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $18.07 | $7.06 |
| Revenue Next Year | $12.74 | $47.01 |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $9.20 | $1.11 |
| 52 Week High | $13.61 | $6.94 |
Technical Indicators
Market Signals| Indicator | VINP | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 48.27 | 45.33 |
| Support Level | $10.56 | $3.17 |
| Resistance Level | $10.92 | $3.94 |
| Average True Range (ATR) | 0.43 | 0.22 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 37.89 | 36.12 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.